Occlutech’s Post

🔍 A small study that we have performed at our department: Until 2021, we assembled and primed each ECMO circuit only when urgently needed, often in the high-stress context of refractory cardiac arrest or cardiogenic shock. In addition to the ECMO setup, the same team had to manage patient care on multiple fronts, including sedation, airway, hemodynamics or resuscitation - a truly exhausting process. 😫 In 2021, we shifted our approach by pre-assembling and pre-priming ECMO circuits, keeping them on stand-by (500 rpm) in the cath lab. This pre-emptive strategy, with circuits remaining sterile for at least 3 weeks, correlated with a significant reduction in door-to-ECMO time and a noticeable improvement in the team’s well-being. 💔 https://lnkd.in/d7Ys8gbR Sonia Lech Andreas Diefenbach Wulf Knie Ulf Landmesser Carsten Skurk

Check out episode #118 of the podcast, "Walking Home From the ICU" to hear about how an ECMO team decreased COVID mortality by 30% through early mobility. #COVID #COVID19 #earlymobility #abcdefbundle #awakeandwalkingicu #ECMO #ECMOprofusionist #awakeandwalkingicu #ICUdelirium #ICU

🚨 HAPPENING NEXT WEEK: Join us for a webinar with our panel of experts who will answer all your questions about the PaceArt acquisition. Learn how we are committed to supporting you and what upgrade options might be available for you. #PaceArt #PaceArtAcquisition #MedtronicPaceArt #EPeeps

YHLO provides solutions for🫀myocardial injury and 🚒 myocardial infarction. One of the major solutions is high-sensitivity cardiac troponin (hs-cTn), a cardiac biomarker. 🔑Some key features of hs-cTn: 🧪 Limit of Detection (LoD): hs-cTn tests can detect very low levels of troponin, typically in the range of nanograms per liter (ng/L). The lower the LoD, the higher the sensitivity. ✅ Coefficient of Variation (CV): At low concentrations (usually around the 99th percentile cutoff), the CV for hs-cTn tests should be less than 10%, ensuring accuracy and reliability. 📊 99th Percentile Cutoff: This is the level of hs-cTn where 99% of healthy people fall below. It helps distinguish between normal and abnormal levels. The cutoff can vary by gender, age, and race... ⏱️ Delta Change (Δ Change): The change in hs-cTn levels over a short period (like 1-3 hours) is crucial for diagnosing acute heart injuries. Significant increase or decrease indicate myocardial injury. 🏃Keep exploring, stay eager.

As a global leader in health technology, we continue to build upon the way we innovate and advocate for greater access to care, in collaboration with customers and organizations around the world.  This includes increasing access to treatments like mechanical thrombectomy – a proven, minimally invasive interventional procedure that removes the blood clot that causes a stroke. It has the potential to revolutionize treatment for major ischemic strokes but only a small percentage of people eligible for this treatment get it in time. With one in four people being affected by stroke in their lifetime, the impact on the healthcare system and society is enormous. In 2023, Philips signed a two-year partnership with the World Stroke Organization focused on advocacy, education, and raising awareness of driving access to stroke care as a global healthcare challenge. Today, we launched a joint policy paper to provide recommendations for effective policy making and investments in stroke centers with specialized treatments to improve health outcomes and reduce costs. You can download the paper here: https://lnkd.in/efGd8ZPH

UPCOMING DEMO | Join Research Application Specialist, Peter Burlingame, for a virtual demonstration of the NEW Millar MPVS Duo on December 12th! Register here 👉 https://bit.ly/3C0I6J3 👈 This virtual demonstration will cover: ☑️New features of the MPVS Duo system ☑️How to navigate the Duo’s guided user interface ☑️How to set-up the Duo, catheter, and accessories ☑️LabChart’s new PV Loop 2.6 Module ☑️The benefits of Millar’s catheter based pressure-volume technology over other cardiovascular assessment tools #ADInstruments #CardiovascularResearch #PressureVolume

Here are some ways Philips helped deliver better care for more people in Q3 2024. For my reflections on our results, watch my update ▶ ➡ Innovating to improve lives – such as expanding our next-generation cardiovascular ultrasound platform with FDA clearance of two additional AI algorithms to enhance structural heart disease examinations as part of the global rollout of this technology. ➡ Signing of multiple partnerships – including with Carilion Clinic in the US, which will expand cardiac care access through 11 specialized Philips interventional suites, allowing physicians to treat patients with complex cardiovascular conditions closer to home. ➡ Giving parents peace of mind – launching the AI-powered Avent Premium Connected Baby Monitor, which offers cry translation and SenseIQ technology to track sleep, breathing, and movements. Read more here: https://lnkd.in/e5XPvQS7

Discover the power of streamlined AI-driven lung screening with contextflow ADVANCE Chest CT integrated into mint Lesion from Mint Medical, a Brainlab company. With automated lung nodule detection and segmentation, contextflow highlights findings directly within the mint Lesion platform, allowing users to review, adjust, or add insights seamlessly. mint Lesion supports the Lung-RADS 2022 guidelines, featuring built-in automated scoring to enhance accuracy and consistency in lung nodule evaluation. For high-risk patients, contextflow ADVANCE Chest CT extends its capabilities beyond nodules, assisting in the analysis of COPD and *coming soon* identifying calcifications in coronary vessels, equipping users with deeper insights for comprehensive care. Explore how the innovative solution is now integrated into the cutting-edge deepc OS® AIR® ecosystem. Check out this brief video to see it in action😀https://zurl.co/1J7G And then come visit us at any of our company booths at #RSNA24!

In 1931, Dr. John Gibbon stood by a patient’s bedside, helpless as her lungs failed. That moment sparked a vision—a machine that could breathe and pump for those whose organs couldn’t. Decades later, Dr. Robert Bartlett transformed this dream into ECMO, creating a lifeline for critically ill patients of all ages. Inspired by this legacy, Liu Yang, Li Yijiang and Mingtao Li, set out to redefine the role of ECMO in modern healthcare. After years immersed in Germany’s advanced medical field, they returned to China to launch CBM Lifemotion. Their mission? To make ECMO technology accessible and bring new hope to patients everywhere. For Liu, Li, and Mingtao it’s not just about machines—it’s about giving life a second chance. Today, CBM Lifemotion carries this vision forward, advancing ECMO technology to save lives, inspire hope, and make life-saving support accessible to all. This mission is what sparks me each day, driving my commitment to push boundaries and bring new possibilities to patients around the world. Stay tuned—exciting developments are on the way! #CBMLifemotion #ECMO #MedicalInnovation #LifeSupport

The radial tools exist. The time is now. Attend the New Cardiovascular Horizons symposium to learn how top interventionalists are using the Sublime™ Radial Access Platform to make radial-to-peripheral interventions not just possible, but practical. Rx only. #NCVH2024 #radialrev #radialfirst https://hubs.ly/Q02wyRxH0